CNTB
Connect Biopharma Holdings
CNTB
CNTB
16 hedge funds and large institutions have $11.7M invested in Connect Biopharma Holdings in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$33K | |
| 2 | +$26.7K | |
| 3 | +$11K | |
| 4 |
Renaissance Technologies
New York
|
+$7.24K |
Top Sellers
| 1 | -$427K | |
| 2 | -$231K | |
| 3 | -$33.5K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.34K |